HeartSync Multifunction Disposable Single-Use Defibrillator Pads
Graphic Controls D.B.A. Vermed · Decision date Dec 19, 2025
What did the FDA decide?
FDA records P200007/S002 as a supplement to PMA P200007, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 19, 2025.
FDA approval order statement
a modification of the primary packaging pouch for the HeartSync Multifunction Disposable Single-Use AED defibrillator pad, T100AC-Zoll-10, and T100-CS
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Dec 19, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P200007/S002
- Regulatory pathway
- PMA supplement
- Applicant
- Graphic Controls D.B.A. Vermed
- Product code
- MKJ
- Decision code
- OK30
- Decision date
- Dec 19, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- Graphic Controls D.B.A. Vermed
- Product code
- MKJ
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P200007/S001 · Related supplement
HeartSync Multifunction Disposable Single-Use AED Defibrillator Pads
P200007/S002 received
Application receipt date recorded by FDA.
P200007/S002 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P200007. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200007
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Graphic Controls D.B.A. Vermed | PMA supplement | Nov 12, 2025 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| ZOLL MEDICAL CORPORATION | PMA supplement | Oct 2, 2026 | FDA | |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Graphic Controls D.B.A. Vermed
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 400 Exchange St., Buffalo, NY, 14204
Sources and methodology
- Original FDA record: P200007/S002
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

